Fainting News and Research

RSS

Return to play can be managed for athletes with genetic heart diseases, study suggests

Receiving the diagnosis of a genetic heart disease such as long QT syndrome, which can cause sudden cardiac death, has long been a game-ender for young athletes. But a 20-year study at Mayo Clinic following such athletes who were allowed to return to play suggests that the risks can be managed through a shared decision-making process.

27 Jul 2021

Long-term exposure to air pollutants increases the risk of dysmenorrhea in women

Dysmenorrhea, that is, frequent severe and painful cramps during menstruation from abnormal contractions of the uterus, is the most common of all gynecological disorders. It affects between 16-91% of girls and women of reproductive age, of whom 2%-29% have symptoms severe enough to restrict their daily activity.

6 Jul 2021

Landmark study confirms that controlled blood pressure is key to prevent stroke, heart disease

Follow-up data from the landmark SPRINT study of the effect of high blood pressure on cardiovascular disease have confirmed that aggressive blood pressure management -- lowering systolic blood pressure to less than 120 mm Hg -- dramatically reduces the risk of heart disease, stroke, and death from these diseases, as well as death from all causes, compared to lowering systolic blood pressure to less than 140 mm Hg.

22 May 2021

Guidance on diagnosis and management of cerebral venous sinus thrombosis after a COVID-19 vaccine

Last Friday, the Centers for Disease Control and Prevention and the U.S. Food & Drug Administration lifted the pause in administration of the Johnson & Johnson (Janssen) COVID-19 vaccine in the U.S.

29 Apr 2021

Michigan Medicine to kick off first national study on allergic reactions to COVID-19 vaccines

In a carefully controlled study, Michigan Medicine researchers will kick off the first national trial to study allergic reactions to the COVID-19 mRNA vaccines.

7 Apr 2021

Low-intensity exercise not enough to counteract effects of long-term weightlessness on the heart

As NASA seeks to build a lunar outpost, visit Mars and commercialize spaceflight, the long-term effects of weightlessness on the human heart are of critical importance, according to researchers.

29 Mar 2021

‘I wanted to go in there and help’: Nursing schools see enrollment bump amid pandemic

Last December, Mirande Gross graduated from Bellarmine University in Louisville, Kentucky, with a bachelor's degree in communications.

18 Feb 2021

Study offers a new way to treat children with bow hunter syndrome

Fusing the neck's top two vertebrae can prevent repeat strokes in children with bow hunter syndrome, a rare condition that affects a handful of U.S. pediatric patients each year, UT Southwestern researchers suggest in a recent study.

11 Feb 2021

Medical institutions should support health care workers with COVID-19 infection, say experts

By mid-November, the Centers for Disease Control and Prevention had reported that 218,439 health care workers in the U.S. had been infected with COVID-19 -- a likely underestimate due to incomplete data from states.

13 Jan 2021

Is your covid vaccine venue prepared to handle rare, life-threatening reactions?

As the rollout of covid-19 vaccines picks up across the U.S., moving from hospital distribution to pharmacies, pop-up sites and drive-thru clinics, health experts say it's vital that these expanded venues be prepared to handle rare but potentially life-threatening allergic reactions.

11 Jan 2021

Wearable technology could transform how patients manage type 1 diabetes

A PRODUCT design graduate from the University of Huddersfield has defeated thousands of entries from around the world to become one of the finalists of the 2020 Global Grad Show with their design for a discrete earring that monitors blood sugar levels and delivers feedback in real-time.

9 Dec 2020

Updated guideline on hypertrophic cardiomyopathy encourages shared decision-making

The American Heart Association and the American College of Cardiology today released an updated guideline for managing patients with hypertrophic cardiomyopathy (HCM).

22 Nov 2020

Low‐dose ketamine does not alter a healthy human's tolerance to blood loss

A low dose of ketamine, administered intravenously, does not alter a healthy human's tolerance to blood loss. In other words, if someone was given ketamine to kill pain associated with a battlefield injury, they would be able to tolerate blood loss just as well as someone who did not received this pain killer.

21 Oct 2020

Azithromycin use for treating COVID-19 may increase risk of cardiac events

Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug's reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.

16 Sep 2020

Study: Mavacamten improves heart function in patients with hypertrophic cardiomyopathy

Mavacamten improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy, according to results of the EXPLORER-HCM trial presented in a Hot Line session today at ESC Congress 2020.

31 Aug 2020

Glenfield Hospital first in the UK and Ireland to implant world’s smallest, wireless pacemaker

Glenfield Hospital has become the first hospital in the UK and Ireland to implant the world’s smallest, wireless pacemaker - the size of a large vitamin - into a patient’s heart.

26 Jun 2020

New study to analyze risks posed by heat wave and COVID-19

As the United States nears its hottest time of the year, scientists are launching a research project into whether the public health impacts of extreme heat will be amplified by the COVID-19 pandemic.

23 Jun 2020

New procedure rewires the heart to treat patient suffering from recurrent fainting spells

A procedure conducted for the first time in the United States at University of Chicago Medicine has provided much-needed relief for a patient who suffered from recurrent fainting spells.

10 Jun 2020

Seniors with COVID-19 show unusual symptoms, doctors say

Older adults with COVID-19, the illness caused by the coronavirus, have several "atypical" symptoms, complicating efforts to ensure they get timely and appropriate treatment, according to physicians.

24 Apr 2020

Investigational drug vericiguat benefits patients with worsening heart failure

Patients with worsening heart failure and reduced ejection fraction who received the investigational drug vericiguat had a significantly lower rate of cardiovascular death or heart failure hospitalization compared with those receiving a placebo, based on research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020